Papp L Roy & Associates Has $6.40 Million Position in Stryker Corporation (SYK)
Papp L Roy & Associates increased its stake in shares of Stryker Corporation (NYSE:SYK) by 5.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,063 shares of the medical technology company’s stock after buying an additional 2,285 shares during the quarter. Stryker Corporation accounts for about 1.4% of Papp L Roy & Associates’ investment portfolio, making the stock its 26th largest position. Papp L Roy & Associates’ holdings in Stryker Corporation were worth $6,400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors also recently bought and sold shares of the stock. Jarislowsky Fraser Ltd lifted its position in shares of Stryker Corporation by 84.8% during the 3rd quarter. Jarislowsky Fraser Ltd now owns 8,634 shares of the medical technology company’s stock worth $1,226,000 after buying an additional 3,961 shares during the period. Retirement Systems of Alabama lifted its position in shares of Stryker Corporation by 2.5% during the 3rd quarter. Retirement Systems of Alabama now owns 234,870 shares of the medical technology company’s stock worth $33,356,000 after buying an additional 5,656 shares during the period. HM Payson & Co. lifted its position in shares of Stryker Corporation by 64.2% during the 3rd quarter. HM Payson & Co. now owns 6,716 shares of the medical technology company’s stock worth $954,000 after buying an additional 2,625 shares during the period. Sei Investments Co. lifted its position in shares of Stryker Corporation by 26.8% during the 3rd quarter. Sei Investments Co. now owns 41,104 shares of the medical technology company’s stock worth $5,838,000 after buying an additional 8,696 shares during the period. Finally, Global X MANAGEMENT CO LLC lifted its position in shares of Stryker Corporation by 15.1% during the 3rd quarter. Global X MANAGEMENT CO LLC now owns 6,573 shares of the medical technology company’s stock worth $933,000 after buying an additional 862 shares during the period. Institutional investors and hedge funds own 74.15% of the company’s stock.
SYK has been the subject of several analyst reports. Piper Jaffray Companies restated an “overweight” rating and set a $148.00 target price on shares of Stryker Corporation in a research report on Thursday, August 24th. Needham & Company LLC upgraded Stryker Corporation from an “underperform” rating to a “hold” rating in a research report on Friday, August 25th. Zacks Investment Research upgraded Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 price objective for the company in a research report on Monday, July 17th. BidaskClub downgraded Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Saturday, August 26th. Finally, Stifel Nicolaus lifted their price objective on Stryker Corporation from $151.00 to $158.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. Stryker Corporation currently has a consensus rating of “Hold” and a consensus target price of $151.52.
In related news, insider Lonny J. Carpenter sold 5,000 shares of Stryker Corporation stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total transaction of $776,700.00. Following the completion of the sale, the insider now directly owns 83,207 shares of the company’s stock, valued at $12,925,375.38. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 7.40% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: This news story was reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://www.watchlistnews.com/papp-l-roy-associates-has-6-40-million-position-in-stryker-corporation-syk/1700396.html.
Shares of Stryker Corporation (SYK) traded down $2.14 during trading on Monday, hitting $154.48. The company had a trading volume of 1,267,200 shares, compared to its average volume of 1,183,556. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. Stryker Corporation has a twelve month low of $106.48 and a twelve month high of $160.62. The firm has a market capitalization of $58,100.00, a PE ratio of 24.48, a PEG ratio of 2.43 and a beta of 0.79.
Stryker Corporation (NYSE:SYK) last announced its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.50 by $0.02. Stryker Corporation had a return on equity of 24.11% and a net margin of 14.67%. The business had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. During the same period in the previous year, the firm earned $1.39 earnings per share. The firm’s quarterly revenue was up 6.1% compared to the same quarter last year. research analysts predict that Stryker Corporation will post 6.47 earnings per share for the current fiscal year.
Stryker Corporation Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.